This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WEX To Serve As Presenting Sponsor Of Maine Cancer Foundation’s Tri For A Cure For 2013, 2014 And 2015

WEX Inc. (NYSE: WXS), a leading international provider of physical, digital and virtual corporate card payment solutions, today announced that it will serve as the Presenting Sponsor of the Tri for a Cure event for Maine Cancer Foundation (MCF), a statewide source of cancer grant funding, from 2013 to 2015. At the invitation of MCF executive director, Tara Hill, WEX chairman, president and CEO, Michael E. Dubyak, delivered opening remarks to a group of more than 250 business leaders at the Portland Regional Chamber of Commerce breakfast on December 5 announcing the three year gift.

“Maine Cancer Foundation is deeply committed to cancer research, education and patient support ― and WEX is deeply committed to its mission to find a cure and to support the people of Maine who find themselves affected by this disease,” said Dubyak. “It was our honor and our privilege to serve as the MCF Tri for a Cure Presenting Sponsor in 2012, a record-breaking event that raised $1,200,000. We made the decision to sponsor the Tri for a Cure for the next three years for many reasons including the fact that 100% of funds raised by Maine Cancer Foundation stay in Maine and are reinvested back in our community.”

“We are deeply appreciative of all that WEX has done for MCF and the Maine community and we look forward to making an even greater impact together through the Tri for a Cure event over the next three years,” said Tara Hill, executive director of MCF. “Investing in organizations like MCF is a triple-win for the business community in that it provides outlets for community involvement, actively attracts talent and federal money to the state, and it has a serious and lasting effect on medical research for cancer ― the No. 1 cause of death in our state.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,978.25 -56.68 -0.31%
S&P 500 2,102.13 +1.73 0.08%
NASDAQ 5,019.6940 +25.0920 0.50%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs